Class II · Moderate risk Ongoing
Pantoprazole Sodium
Reason Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
Pantoprazole Sodium Delayed Release Tablets USP
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
cGMP Deviations: Oral products were not manufactured in accordance with Good Manufacturing Practices.
What was recalled
Pantoprazole Sodium Delayed Release Tablets USP, 40 mg, 90 count bottles, Manufactured by Jubilant Life Sciences Ltd, Roorkee-247661 India ;Marketed by Jubilant Cadista Pharmaceuatical Inc Salisbury, MD 21801 NDC 59746-284-90
- Recalling firm
- Jubilant Cadista Pharmaceuticals Inc.
- NDC code
- 59746-284-90
- Origin
- MD, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-296-2013
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Pantoprazole recalls
See all
Class II · Moderate risk Terminated
Pantoprazole Sodium for Injection 40mg per vial
Reason Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
Class II · Moderate risk Completed
Pantoprazole sodium for Injection 40 mg*/vial
Reason CGMP Deviations; The impacted product and lot number was inadvertently placed into saleable inventory, which does not comply with approved procedures.
Class II · Moderate risk Ongoing
Pantoprazole Sodium Delayed Release Tablets USP 40mg
Reason CGMP Deviations: Discoloration
Class II · Moderate risk Terminated
Pantoprazole 30mg in Ns 7.5ml
Reason Lack of sterility assurance
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.